Therapeutic Peptide Screening Service

MtoZ Biolabs provides integrated Therapeutic Peptide Screening Services, combining advanced display technologies, high-throughput functional screening, and bioinformatics-driven analysis to accelerate the discovery of bioactive peptides with therapeutic potential. Our comprehensive therapeutic peptide screening platform supports multiple peptide categories, including antimicrobial, anti-inflammatory, antioxidant, antiviral, antitumor, and neuroactive peptides. 

 

What Is Therapeutic Peptide?

Therapeutic peptides are short, biologically active amino acid chains capable of modulating molecular interactions in cellular and physiological processes. Their moderate size, high specificity, and customizable structure make them attractive candidates for targeted drug discovery. Therapeutic peptides provide:

🔸High affinity and selectivity toward target proteins or receptors

🔸Reduced toxicity and immunogenicity

🔸Flexible chemical modification options for stability and bioavailability

🔸Favorable pharmacokinetic and tissue penetration profiles

Because of these features, therapeutic peptides have become indispensable in developing drugs for infections, cancer, inflammatory disorders, and neurological diseases. 

Therapeutic peptide screening involves identifying peptides with specific bioactivities or binding capabilities through systematic evaluation. It integrates combinatorial display systems, functional assays, and analytical validation to uncover potent sequences. By exploring large peptide libraries, researchers can isolate candidates with strong target specificity and pharmacological promise. Efficient therapeutic peptides screening is vital to identify sequences that combine high activity with safety and stability, facilitating the design of next-generation therapeutics.

  



 

Wang, L. et al. Signal Transduct Target Ther. 2022.

 

Figure 1. Application of Peptides in Tumor Therapy 

 

Therapeutic Peptide Screening Service at MtoZ Biolabs

At MtoZ Biolabs, we employ a multi-platform screening workflow that unites phage display, yeast display, bacterial display, and cell surface display technologies. These complementary systems allow the selection of peptide ligands from vast libraries, both natural and synthetic, and ensure the isolation of sequences with high binding affinity and functional activity. Through iterative rounds of selection, specificity testing against relevant targets, and activity validation assays, we provide researchers with reliable, high-confidence peptide candidates suitable for therapeutic development.

Our Therapeutic Peptide Screening Service includes:

💠Antimicrobial Peptide Discovery Service: Screening for peptides that inhibit bacterial, fungal, or viral growth.

💠Anti-inflammatory Peptides Screening Service: Identification of peptides regulating cytokine production and inflammatory responses.

💠Antioxidant Peptides Screening Service: Selection of peptides that neutralize reactive oxygen species and prevent oxidative damage.

💠Antiviral Peptides Screening Service: Discovery of peptides that block viral attachment, entry, or replication.

💠Antitumor Peptides Screening Service: Characterization of peptides inducing apoptosis, inhibiting angiogenesis, or suppressing tumor proliferation.

💠Neuropeptides Screening Service: Detection of peptides affecting neurotransmission, cognitive modulation, and neuroprotection.

Each service combines display-based library screening with in vitro functional testing and LC-MS/MS characterization to ensure the discovery of biologically validated peptide leads.

 

Workflow of Therapeutic Peptide Screening Service

1. Consultation and Experimental Design

Define research objectives, targets, and desired peptide properties.

2. Library Preparation and Display Setup

Construct or select natural or synthetic peptide libraries using phage, yeast, bacterial, or cell display systems.

3. Screening and Selection

Perform iterative rounds of binding, washing, and elution to enrich for peptides exhibiting high affinity and specificity.

4. Functional Assays

Validate the biological activity of enriched peptides through cell viability, signaling, or inhibition assays.

5. Analytical Characterization

Confirm purity and sequence integrity using LC-MS/MS and chromatographic analysis.

6. Data Integration and Reporting

Provide a comprehensive dataset of peptide candidates, experimental parameters, and biological performance.

 

Why Choose MtoZ Biolabs

✔️Extensive peptide library resources covering natural and synthetic sequences.

✔️Multiple display platforms allowing flexible and efficient selection.

✔️Customizable workflows tailored to specific biological targets.

✔️Integrated validation combining binding, activity, and analytical data.

✔️Professional scientific team with deep expertise in peptide discovery and bioanalysis.

 

Applications of Therapeutic Peptide Screening Service

Therapeutic peptide screening at MtoZ Biolabs supports a broad range of research and development applications:

• Identification of new therapeutic leads for infection, cancer, and metabolic disorders
• Development of receptor-targeting ligands and biologics
• Discovery of peptides for vaccine design and immune modulation
• Drug delivery targeting using tumor- or tissue-specific peptides
• Mechanistic exploration of peptide–receptor interactions

 

FAQ

Q1: What types of samples are suitable?

We accept a wide range of sample types, including recombinant or expressed peptides, protein targets, biological fluids, tissue, and cells. For other sample types or projects with specific requirements, please contact MtoZ Biolabs in advance for tailored preparation guidance.

 

Q2: How should I prepare my samples?

1. Ensure samples are freshly prepared or snap-frozen.

2. Avoid using detergents, reducing agents, or preservatives that may interfere with LC-MS/MS analysis.

3. Store samples at –80 °C before shipment.

4. Transport samples on dry ice to maintain stability during delivery.

 

For more information, please refer to Sample Submission Guidelines for Proteomics.

 

Q3: What is the service general workflow?

 



 

Q4: What data formats are provided?

1. Comprehensive result reports provided in PDF format, including experimental workflow, screening results, and interpretation.

2. Raw and processed data files available in Excel or CSV format for convenient secondary analysis.

3. Sequence and spectral data from LC-MS/MS or peptide identification provided in standard formats such as FASTA and mzML.

4. Visual data outputs, including activity curves and comparison charts, delivered in high-resolution image formats such as PNG or TIFF.

5. Additional formats can be provided upon request to meet specific analysis or publication requirements.

 

Start Your Project with MtoZ Biolabs

Contact us today to discuss your project or request a quotation. MtoZ Biolabs empowers therapeutic peptide discovery through an integrated screening platform that combines display technology, functional validation, and precise analytical characterization. Our streamlined process helps clients efficiently identify peptides with strong biological activity and drug development potential.